MAUSMODELLE UND THERAPEUTISCHE MOLEKÜLE

European patent · EP3609319 · In force

Register entry

Publication number
EP3609319
Application number
EP18719629
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 10, 2018
Published
Feb 19, 2020
Granted
Feb 26, 2025
Protection ends at the latest
Apr 9, 2038
Next annual fee due
Apr 30, 2027
IPC classes
A01K 67/0278 (2024.01)
C07K 16/00 (2006.01)
C07K 16/46 (2006.01)
C12N 5/0781 (2010.01)
Priority
GB 201705725 10.04.2017
PCT application
PCT/GB2018/050946 10.04.2018
PCT publication
WO2018/189520 18.10.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. Jan 7, 2026

    Change

    Published in Swissreg on 07.01.2026

  3. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  4. Feb 26, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.02.2025

Parties

Holder

Genome Research Limited

Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, GB

Inventor

MARTIN, Jolyon Nicolas Edouard

Hinxton Cambridgeshire CB10 1SA, GB

BRADLEY, Allan

Hinxton Cambridgeshire CB10 1SA, GB

Licensee

Petmedix Ltd.

The Glenn Berge Building 940 Babraham Research Campus, Babraham, Cambridge CB22 3FH, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.